Jong Seog Ahn Selected Research

kurarinone

5/2022

Kurarinone induced p53-independent G0/G1 cell cycle arrest by degradation of K-RAS via WDR76 in human colorectal cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jong Seog Ahn Research Topics

Disease

32	Neoplasms (Cancer) 05/2022 - 07/2003
11	Obesity 10/2009 - 02/2006
10	Type 2 Diabetes Mellitus (MODY) 10/2009 - 09/2005
5	Prostatic Neoplasms (Prostate Cancer) 09/2015 - 11/2006
3	Hypoxia (Hypoxemia) 12/2019 - 01/2017
3	Carcinogenesis 01/2018 - 03/2004
2	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 04/2012
2	Melanoma (Melanoma, Malignant) 04/2020 - 05/2014
2	Skin Neoplasms (Skin Cancer) 04/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2018 - 07/2010
2	Infections 01/2015 - 07/2014
2	Hepatocellular Carcinoma (Hepatoma) 05/2013 - 12/2011
2	Osteoporosis 02/2013 - 06/2012
2	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2008 - 08/2007
1	Brain Diseases (Brain Disorder) 01/2022
1	Neuroblastoma 12/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 09/2021
1	Leukemia 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Atopic Dermatitis (Atopic Eczema) 11/2018
1	Experimental Melanoma 05/2014
1	Metabolic Diseases (Metabolic Disease) 06/2012
1	Colonic Neoplasms (Colon Cancer) 04/2012
1	Carcinoma (Carcinomatosis) 06/2011

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 04/2020 - 09/2005
9	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 08/2009 - 09/2005
6	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2006
4	Biological ProductsIBA 12/2021 - 06/2011
3	muconomycin AIBA 09/2013 - 02/2013
3	LigandsIBA 05/2013 - 12/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 12/2011
3	NF-kappa B (NF-kB)IBA 04/2008 - 08/2005
2	FlavonoidsIBA 05/2022 - 12/2019
2	EnzymesIBA 01/2022 - 12/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2018
2	STK899704IBA 01/2018 - 01/2017
2	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2015 - 05/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2015 - 07/2012
2	TensinsIBA 09/2015 - 07/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2015 - 07/2012
1	kurarinoneIBA 05/2022
1	AcetylcholinesteraseIBA 01/2022
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2021
1	pipecolic acidIBA 01/2021
1	DepsipeptidesIBA 01/2021
1	Death Domain ReceptorsIBA 04/2020
1	beauvericinIBA 04/2020
1	streptimidoneIBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 12/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 12/2019
1	TransferasesIBA 05/2019
1	Decitabine FDA Link 05/2019
1	DNA (Deoxyribonucleic Acid)IBA 05/2019
1	Filaggrin ProteinsIBA 11/2018
1	Peptide Nucleic AcidsIBA 11/2018
1	Peptides (Polypeptides)IBA 10/2018
1	Angiogenesis InhibitorsIBA 03/2018
1	elaiophylinIBA 03/2018
1	Tubulin ModulatorsIBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Polo-Like Kinase 1IBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	eupafolinIBA 09/2015
1	pectate lyaseIBA 01/2015
1	brassininIBA 07/2014
1	Melanins (Melanin)IBA 05/2014
1	SesquiterpenesIBA 05/2014
1	1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA 05/2014
1	TrichothecenesIBA 09/2013
1	oligomycin AIBA 02/2013
1	salubrinalIBA 02/2013
1	TNF-Related Apoptosis-Inducing LigandIBA 02/2013
1	OligomycinsIBA 02/2013
1	4,4'- (3H,3'H- 5,5'- bibenzimidazole- 2,2'- diyl)dianilineIBA 01/2013
1	CamptothecinIBA 01/2013
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2013
1	Etoposide (VP 16)FDA LinkGeneric 01/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2012
1	Antineoplastic Agents (Antineoplastics)IBA 11/2012
1	geldanamycinIBA 11/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 07/2012
1	aloe emodinIBA 07/2012
1	DiketopiperazinesIBA 06/2012
1	Oxepins (Oxepin)IBA 06/2012
1	protuboxepin AIBA 06/2012
1	ginsenoside Rh2IBA 06/2012
1	Caspase 3 (Caspase-3)IBA 04/2012
1	PatulinIBA 04/2012
1	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 12/2011
1	asperlinIBA 06/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2011
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 05/2011
1	MitogensIBA 05/2011
1	TunicamycinIBA 05/2011
1	benzyloxycarbonyl- isoleucyl- glutamyl(O- tert- butyl)- alanyl- leucinalIBA 05/2011

Therapy/Procedure

16	Therapeutics 01/2020 - 08/2005
1	Immunotherapy 12/2019